🔴 Pyxis Oncology is trading 5.25% down today as risk-off pressure hits growth stocks and biotech

Pyxis Oncology is trading 5.25% down at $3.25 as broader risk-off pressure hits growth stocks and biotechnology on September 15, 2026.

• The 10-year Treasury yield reached 5.02%, while major U.S. indexes declined and biotech ETF XBI fell 2.11%.
• Recent MICVO trial updates were positive overall, although analysts flagged safety liabilities.
• No new company-specific negative announcement was found for September 15.